Urologiia (Moscow, Russia : 1999) · 2026
[Efficiency of serotonin in the prevention of postoperative ileus in patients after robot-assisted radical prostatectomy].
СтатьяРандомизированное исследованиеАннотация на английскомНазвание и аннотация: Оригинал на русском
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bykova K M, Lisovoy M D, Rutkovsky R V, Shmakova Ya D, Rodchenko A M, Izotov G M, Yechmaeva Ya V, Yablonskikh D D, Shepieva G Z, Shelipanov D A, Mosoyan M S, Aleksandrovich Yu S, Savvina I A
Аннотация
INTRODUCTION: Postoperative ileus is a transient impairment of gastrointestinal motility that occurs after surgery and anesthesia. Currently, there is a sustained trend toward investigating the role of serotonin as a regulator of intestinal motor function.
AIM: To evaluate the clinical efficiency of serotonin (Dinaton) in the prevention of postoperative ileus, pain severity, and hemostasis parameters in patients after robot-assisted radical prostatectomy (RARP).
MATERIALS AND METHODS: A single-center prospective randomized controlled clinical study was conducted and included 70 patients after RARP. In the postoperative period, patients were divided into two groups: the main group and the control group. Patients in the main group received Dinaton in accordance with the official prescribing information. Assessment time points were 10, 24, 48, and 72 hours after surgery. Clinically, patients were evaluated using the VAS (visual analogue scale) and VAS-BLOAT scales. Laboratory assessment included serial measurements of C-reactive protein (CRP) and serum hemoglobin. Drain output volume and the occurrence of defecation were also recorded.
RESULTS: In the group receiving Dinaton, a significant decrease in CRP was observed at 48 hours (=0,00011). No significant differences were found between the main and control groups in hemoglobin levels or drain output volume (p>0,05). According to the VAS, significantly lower postoperative pain intensity persisted throughout the 72-hour period in the main group, along with a reduced need for analgesics compared with the control group. Abdominal bloating was less pronounced in the Dinaton group (VAS-BLOAT) over three days (p<0,05).
CONCLUSION: Use of serotonin in urological patients after RARP significantly reduced pain intensity and abdominal bloating and decreased CRP levels, indicating a more rapid normalization of the systemic inflammatory response.
AIM: To evaluate the clinical efficiency of serotonin (Dinaton) in the prevention of postoperative ileus, pain severity, and hemostasis parameters in patients after robot-assisted radical prostatectomy (RARP).
MATERIALS AND METHODS: A single-center prospective randomized controlled clinical study was conducted and included 70 patients after RARP. In the postoperative period, patients were divided into two groups: the main group and the control group. Patients in the main group received Dinaton in accordance with the official prescribing information. Assessment time points were 10, 24, 48, and 72 hours after surgery. Clinically, patients were evaluated using the VAS (visual analogue scale) and VAS-BLOAT scales. Laboratory assessment included serial measurements of C-reactive protein (CRP) and serum hemoglobin. Drain output volume and the occurrence of defecation were also recorded.
RESULTS: In the group receiving Dinaton, a significant decrease in CRP was observed at 48 hours (=0,00011). No significant differences were found between the main and control groups in hemoglobin levels or drain output volume (p>0,05). According to the VAS, significantly lower postoperative pain intensity persisted throughout the 72-hour period in the main group, along with a reduced need for analgesics compared with the control group. Abdominal bloating was less pronounced in the Dinaton group (VAS-BLOAT) over three days (p<0,05).
CONCLUSION: Use of serotonin in urological patients after RARP significantly reduced pain intensity and abdominal bloating and decreased CRP levels, indicating a more rapid normalization of the systemic inflammatory response.